SNX3 and heart failure: Previous studies also confirmed that SNX3 is significantly upregulated in SP and patients with cardiac failure [53, 54], reinforcing the role of SNX3 as a promising downstream target of miR-143-5p but also highlighting the necessity of further investigations to validate their regulatory relationship and functional relevance in pathological processes.